Cargando…
Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252084/ https://www.ncbi.nlm.nih.gov/pubmed/32360327 http://dx.doi.org/10.1016/j.tmaid.2020.101710 |
| _version_ | 1783539086161608704 |
|---|---|
| author | Khambholja, Kapil Asudani, Deepak |
| author_facet | Khambholja, Kapil Asudani, Deepak |
| author_sort | Khambholja, Kapil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7252084 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72520842020-05-28 Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence Khambholja, Kapil Asudani, Deepak Travel Med Infect Dis Article Elsevier Ltd. 2020 2020-04-28 /pmc/articles/PMC7252084/ /pubmed/32360327 http://dx.doi.org/10.1016/j.tmaid.2020.101710 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Khambholja, Kapil Asudani, Deepak Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |
| title | Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |
| title_full | Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |
| title_fullStr | Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |
| title_full_unstemmed | Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |
| title_short | Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence |
| title_sort | potential repurposing of favipiravir in covid-19 outbreak based on current evidence |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252084/ https://www.ncbi.nlm.nih.gov/pubmed/32360327 http://dx.doi.org/10.1016/j.tmaid.2020.101710 |
| work_keys_str_mv | AT khambholjakapil potentialrepurposingoffavipiravirincovid19outbreakbasedoncurrentevidence AT asudanideepak potentialrepurposingoffavipiravirincovid19outbreakbasedoncurrentevidence |